Showing results (1421-1430 of 6,719) with videos related to
Sort By:
Pageof 672
Annals of Hematology|July 11, 2024
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylateFei ChenAnnals of Hematology|August 6, 2024
Rare case of simultaneous occurrence of chronic neutrophil leukemia and T lymphoblastic lymphoma: case report and literature reviewShi-Xuan Wang, Fang Wang, Ye-Chao Tu, et al.Annals of Hematology|July 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patientsStefanie Jilg, Juliana Schwaab, Katja Sockel, et al.Annals of Hematology|July 29, 2024
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort studyJingjing Deng, Xiaoqi Qin, Guangyu Ma, et al.Annals of Hematology|June 27, 2024
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinibYuemin Gong, Yue Li, Xiaoyu Chen, et al.Annals of Hematology|June 25, 2024
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysisAlexander Denk, Matthias Edinger, Daniela Weber, et al.Annals of Hematology|July 2, 2024
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world studyBin Chu, Yu-Tong Wang, Shan Gao, et al.Annals of Hematology|July 4, 2024
Risk factors for Non-Hodgkin's lymphoma in autoimmune disease: a large database analysisSuma Sri Chennapragada, Shriya Goyal, Upasana Agrawal, et al.Annals of Hematology|July 4, 2024
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021Kai Kysenius, Anna Anttalainen, Iiro Toppila, et al.Annals of Hematology|June 28, 2024
Update on kidney injury caused by multiple myelomaLinhui Wang, Chen Liu, Haiyan Song, et al.Pageof 672